Characteristics | Baseline survey | Endline survey | ||
---|---|---|---|---|
Control | Intervention | Control | Intervention | |
 Populationa, n (%) | 4867 | 4685 | 5728 | 4406 |
 Age group, years | ||||
  < 5 | 908 (18.7%) | 852 (18.2%) | 986 (17.2%) | 702 (15.9%) |
  5–15 | 1602 (32.9%) | 1425 (30.4%) | 1727 (30.2%) | 1307 (29.7%) |
  > 15 | 2357 (48.4%) | 2408 (51.4%) | 3015 (52.6%) | 2397 (54.4%) |
 Gender, n (%) | ||||
  Female | 2698 (55.4%) | 2509 (53.6%) | 3310 (57.8%) | 2464 (55.9%) |
  Male | 2169 (44.6%) | 2176 (46.4%) | 2418 (42.2%) | 1942 (44.1%) |
 Malaria infectiona, n (%, 95% CI) | ||||
  Positive | 1103 (28.1, 26.1–30.2) | 967 (25.7, 23.7–27.8) | 621 (13.4, 12.12–14.7) | 163 (4.9, 4.0–5.9) |
  Negative | 2827 (71.9, 69.9–73.9) | 2794 (74.3, 72.2–76.3) | 4029 (86.6, 85.3–87.9) | 3176 (95.1, 94.1–96.0) |
 Bed-net usec, n (%, 95% CI) | ||||
  Yes | 2316 (49.4, 46.4–52.4) | 2969 (65.9,62.6–69.1) | 4568 (79.7, 77.9–81.5) | 3673 (83.4, 81.3–85.3) |
  No | 2375 (50.6, 47.6–53.6) | 1534 (34.1,30.9–37.4) | 1160 (20.3, 18.5–22.2) | 733 (16.6, 14.7–18.7) |